Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial.

Davis SN, Duckworth W, Emanuele N, Hayward RA, Wiitala WL, Thottapurathu L, Reda DJ, Reaven PD; Investigators of the Veterans Affairs Diabetes Trial.

Diabetes Care. 2019 Jan;42(1):157-163. doi: 10.2337/dc18-1144. Epub 2018 Nov 19.

PMID:
30455335
2.

Profiling Heparin-Induced Thrombocytopenia (HIT) Antibodies in Hospitalized Patients With and Without Diabetes.

Prechel M, Hudec S, Lowden E, Escalante V, Emanuele N, Emanuele M, Walenga JM.

Clin Appl Thromb Hemost. 2018 Nov 12:1076029618808915. doi: 10.1177/1076029618808915. [Epub ahead of print]

PMID:
30419766
3.

Facial Growth of Patients With Complete Unilateral Cleft Lip and Palate Treated With Alveolar Bone Grafting at 6 Years.

Doucet JC, Russell KA, Daskalogiannakis J, Mercado AM, Emanuele N, James L, Hathaway RR, Long RE Jr.

Cleft Palate Craniofac J. 2018 Aug 13:1055665618792791. doi: 10.1177/1055665618792791. [Epub ahead of print]

PMID:
30099956
4.

Increasing SBP variability is associated with an increased risk of developing incident diabetic foot ulcers.

Brennan MB, Guihan M, Budiman-Mak E, Kang H, Lobo JM, Sutherland BL, Emanuele N, Huang ES, Sohn MW.

J Hypertens. 2018 Nov;36(11):2177-2184. doi: 10.1097/HJH.0000000000001783.

5.

Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT).

Agrawal L, Azad N, Bahn GD, Ge L, Reaven PD, Hayward RA, Reda DJ, Emanuele NV; VADT Study Group.

Diabetologia. 2018 Feb;61(2):295-299. doi: 10.1007/s00125-017-4473-2. Epub 2017 Nov 3.

6.

BIOTIN INTERFERENCE WITH ROUTINE CLINICAL IMMUNOASSAYS: UNDERSTAND THE CAUSES AND MITIGATE THE RISKS.

Samarasinghe S, Meah F, Singh V, Basit A, Emanuele N, Emanuele MA, Mazhari A, Holmes EW.

Endocr Pract. 2017 Aug;23(8):989-998. doi: 10.4158/EP171761.RA. Epub 2017 May 23. Review.

PMID:
28534685
7.

Standard vs. intensified management of heart failure to reduce healthcare costs: results of a multicentre, randomized controlled trial.

Scuffham PA, Ball J, Horowitz JD, Wong C, Newton PJ, Macdonald P, McVeigh J, Rischbieth A, Emanuele N, Carrington MJ, Reid CM, Chan YK, Stewart S; WHICH? II Trial Investigators.

Eur Heart J. 2017 Aug 7;38(30):2340-2348. doi: 10.1093/eurheartj/ehx259.

8.

Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade.

Palevsky PM, Zhang JH, Seliger SL, Emanuele N, Fried LF; VA NEPHRON-D Study.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1944-1953. Epub 2016 Sep 27.

9.

Visit-to-visit systolic blood pressure variability and microvascular complications among patients with diabetes.

Sohn MW, Epstein N, Huang ES, Huo Z, Emanuele N, Stukenborg G, Guihan M, Li J, Budiman-Mak E.

J Diabetes Complications. 2017 Jan;31(1):195-201. doi: 10.1016/j.jdiacomp.2016.09.003. Epub 2016 Sep 14.

10.

Response to: 'Pharmacokinetic/pharmacodynamic properties and efficacy/safety of U-500R from randomized clinical studies'.

Barnosky A, Shah L, Meah F, Emanuele N, Emanuele MA, Mazhari A.

Postgrad Med. 2016 Sep;128(7):686. doi: 10.1080/00325481.2016.1210477. Epub 2016 Jul 22. No abstract available.

PMID:
27452002
11.

Association of Blood Glucose Control and Lipids With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT).

Azad N, Bahn GD, Emanuele NV, Agrawal L, Ge L, Reda D, Klein R, Reaven PD, Hayward R; VADT Study Group.

Diabetes Care. 2016 May;39(5):816-22. doi: 10.2337/dc15-1897. Epub 2016 Mar 22.

PMID:
27006510
12.

A primer on concentrated insulins: what an internist should know.

Barnosky A, Shah L, Meah F, Emanuele N, Emanuele MA, Mazhari A.

Postgrad Med. 2016 May;128(4):381-90. doi: 10.1080/00325481.2016.1159909. Epub 2016 Mar 17. Review.

PMID:
26924668
13.

Systolic blood pressure variability and lower extremity amputation in a non-elderly population with diabetes.

Budiman-Mak E, Epstein N, Brennan M, Stuck R, Guihan M, Huo Z, Emanuele N, Sohn MW.

Diabetes Res Clin Pract. 2016 Apr;114:75-82. doi: 10.1016/j.diabres.2016.01.010. Epub 2016 Jan 15.

14.

Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs.

Ahuja V, Sohn MW, Birge JR, Syverson C, Budiman-Mak E, Emanuele N, Cooper JM, Huang ES.

J Manag Care Spec Pharm. 2015 Dec;21(12):1214-34.

15.

BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.

Leehey DJ, Zhang JH, Emanuele NV, Whaley-Connell A, Palevsky PM, Reilly RF, Guarino P, Fried LF; VA NEPHRON-D Study Group.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2159-69. doi: 10.2215/CJN.02850315. Epub 2015 Oct 19.

16.

Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes.

Hayward RA, Reaven PD, Emanuele NV; VADT Investigators.

N Engl J Med. 2015 Sep 3;373(10):978. doi: 10.1056/NEJMc1508386. No abstract available.

PMID:
26332555
17.

SELECTIVE HYPOALDOSTERONISM: A REVIEW.

Wilczynski C, Shah L, Emanuele MA, Emanuele N, Mazhari A.

Endocr Pract. 2015 Aug;21(8):957-65. doi: 10.4158/EP14551.RA. Epub 2015 Jun 29. Review.

PMID:
26121445
18.

Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.

Hayward RA, Reaven PD, Wiitala WL, Bahn GD, Reda DJ, Ge L, McCarren M, Duckworth WC, Emanuele NV; VADT Investigators.

N Engl J Med. 2015 Jun 4;372(23):2197-206. doi: 10.1056/NEJMoa1414266. Erratum in: N Engl J Med. 2015 Jul 9;373(2):198.

19.

Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial.

Florez H, Reaven PD, Bahn G, Moritz T, Warren S, Marks J, Reda D, Duckworth W, Abraira C, Hayward R, Emanuele N; VADT Research Group.

Diabetes Obes Metab. 2015 Oct;17(10):949-55. doi: 10.1111/dom.12487. Epub 2015 Jun 17.

20.

The effect of intensive glucose lowering therapy among major racial/ethnic groups in the Veterans Affairs Diabetes Trial.

Saremi A, Schwenke DC, Bahn G, Ge L, Emanuele N, Reaven PD; VADT Investigators.

Metabolism. 2015 Feb;64(2):218-25. doi: 10.1016/j.metabol.2014.10.010. Epub 2014 Oct 17.

21.

Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy.

Zimering MB, Zhang JH, Guarino PD, Emanuele N, McCullough PA, Fried LF; Investigators for the VA NEPHRON-D.

Front Endocrinol (Lausanne). 2014 Aug 11;5:128. doi: 10.3389/fendo.2014.00128. eCollection 2014.

22.

Blood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT).

Anderson RJ, Bahn GD, Emanuele NV, Marks JB, Duckworth WC; VADT Study Group.

Diabetes Care. 2014 Oct;37(10):2782-8. doi: 10.2337/dc14-0284. Epub 2014 Jul 21.

23.

Neurologic complications of diabetes.

Charnogursky GA, Emanuele NV, Emanuele MA.

Curr Neurol Neurosci Rep. 2014 Jul;14(7):457. doi: 10.1007/s11910-014-0457-5. Review.

PMID:
24817097
24.

The association between glycemic control and clinical outcomes after kidney transplantation.

Ramirez SC, Maaske J, Kim Y, Neagu V, DeLange S, Mazhari A, Gao W, Emanuele MA, Emanuele N, Baldwin D, Mihailescu DV.

Endocr Pract. 2014 Sep;20(9):894-900. doi: 10.4158/EP13463.OR.

PMID:
24641922
25.

Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT).

Azad N, Agrawal L, Emanuele NV, Klein R, Bahn GD, Reaven P; VADT Study Group.

Diabetologia. 2014 Jun;57(6):1124-31. doi: 10.1007/s00125-014-3199-7. Epub 2014 Mar 6.

PMID:
24599110
26.

Combined angiotensin inhibition in diabetic nephropathy.

Fried LF, Emanuele N, Zhang JH.

N Engl J Med. 2014 Feb 20;370(8):779. doi: 10.1056/NEJMc1315504. No abstract available.

PMID:
24552328
27.

Neurologic disorders of mineral metabolism and parathyroid disease.

Agrawal L, Habib Z, Emanuele NV.

Handb Clin Neurol. 2014;120:737-48. doi: 10.1016/B978-0-7020-4087-0.00049-8. Review.

PMID:
24365349
28.

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W, Leehey DJ, McCullough PA, O'Connor T, Palevsky PM, Reilly RF, Seliger SL, Warren SR, Watnick S, Peduzzi P, Guarino P; VA NEPHRON-D Investigators.

N Engl J Med. 2013 Nov 14;369(20):1892-903. doi: 10.1056/NEJMoa1303154. Epub 2013 Nov 9. Erratum in: N Engl J Med. 2014;158:A7255.

29.

Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT).

Azad N, Agrawal L, Emanuele NV, Klein R, Bahn GD, McCarren M, Reaven P, Hayward R, Duckworth W; VADT Study Group.

Diabetes Care. 2014 Feb;37(2):501-6. doi: 10.2337/dc13-1193. Epub 2013 Oct 7.

30.

The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial.

Duckworth WC, Abraira C, Moritz TE, Davis SN, Emanuele N, Goldman S, Hayward R, Huang GD, Marks JB, Reaven PD, Reda DJ, Warren SR, Zieve FJ; Investigators of the VADT.

J Diabetes Complications. 2011 Nov-Dec;25(6):355-61. doi: 10.1016/j.jdiacomp.2011.10.003. Epub 2011 Nov 4.

PMID:
22055259
31.

Observation on renal outcomes in the Veterans Affairs Diabetes Trial.

Agrawal L, Azad N, Emanuele NV, Bahn GD, Kaufman DG, Moritz TE, Duckworth WC, Abraira C; Veterans Affairs Diabetes Trial (VADT) Study Group.

Diabetes Care. 2011 Sep;34(9):2090-4. doi: 10.2337/dc11-0175. Epub 2011 Jul 20.

32.

Profiling of heparin-induced thrombocytopenia antibody levels in patients with and without diabetes.

Diaz J, Prechel M, Emanuele M, Emanuele N, Walenga JM.

Clin Appl Thromb Hemost. 2010 Apr;16(2):121-5. doi: 10.1177/1076029609350621.

PMID:
20299390
33.

Duration of diabetes, glucose control and cardiovascular risk.

Emanuele NV.

Diabetologia. 2010 Jan;53(1):214-5. doi: 10.1007/s00125-009-1563-9. Epub 2009 Oct 20. No abstract available.

PMID:
19841889
34.

Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT).

Emanuele N, Moritz T, Klein R, Davis MD, Glander K, Khanna A, Thottapurathu L, Bahn G, Duckworth W, Abraira C; Veterans Affairs Diabetes Trial Study Group.

Diabetes Res Clin Pract. 2009 Nov;86(2):104-10. doi: 10.1016/j.diabres.2009.08.001. Epub 2009 Aug 31.

PMID:
19720420
35.

Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.

Reaven PD, Moritz TE, Schwenke DC, Anderson RJ, Criqui M, Detrano R, Emanuele N, Kayshap M, Marks J, Mudaliar S, Harsha Rao R, Shah JH, Goldman S, Reda DJ, McCarren M, Abraira C, Duckworth W; Veterans Affairs Diabetes Trial.

Diabetes. 2009 Nov;58(11):2642-8. doi: 10.2337/db09-0618. Epub 2009 Aug 3.

36.

Ethanol potentiates the acute fatty infiltration of liver caused by burn injury: prevention by insulin treatment.

Emanuele NV, Emanuele MA, Morgan MO, Sulo D, Yong S, Kovacs EJ, Himes RD, Callaci JJ.

J Burn Care Res. 2009 May-Jun;30(3):482-8. doi: 10.1097/BCR.0b013e3181a28df3.

37.

Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).

Fried LF, Duckworth W, Zhang JH, O'Connor T, Brophy M, Emanuele N, Huang GD, McCullough PA, Palevsky PM, Seliger S, Warren SR, Peduzzi P; VA NEPHRON-D Investigators.

Clin J Am Soc Nephrol. 2009 Feb;4(2):361-8. doi: 10.2215/CJN.03350708. Epub 2008 Dec 31.

38.

Glucose control and vascular complications in veterans with type 2 diabetes.

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT Investigators.

N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17. Erratum in: N Engl J Med. 2009 Sep 3;361(10):1028. N Engl J Med. 2009 Sep 3;361(10):1024-5.

39.

Therapeutic drug monitoring in the management of HIV-infected patients.

Ivanovic J, Nicastri E, Ascenzi P, Bellagamba R, De Marinis E, Notari S, Pucillo LP, Tozzi V, Ippolito G, Narciso P.

Curr Med Chem. 2008;15(19):1925-39. Review. Erratum in: Curr Med Chem. 2008 Dec;15(30):3280. Jelena, Ivanovic [corrected to Ivanovic, Jelena]; Emanuele, Nicastri [corrected to Nicastri, Emanuele]; Paolo, Ascenzi [corrected to Ascenzi, Paolo]; Rita, Bellagamba [corrected to Bellagamba, Rita]; Elisabetta, De Marinis [corrected to De Marinis, Elisabe.

PMID:
18691049
40.

Comparison of dilated fundus examinations with seven-field stereo fundus photographs in the Veterans Affairs Diabetes Trial.

Emanuele N, Klein R, Moritz T, Davis MD, Glander K, Anderson R, Reda D, Duckworth W, Abraira C; VADT Study Group.

J Diabetes Complications. 2009 Sep-Oct;23(5):323-9. doi: 10.1016/j.jdiacomp.2008.02.010. Epub 2008 Apr 11.

PMID:
18406632
41.

Profound effects of burn and ethanol on proinflammatory cytokines of the reproductive axis in the male mouse.

Emanuele NV, LaPaglia N, Kovacs EJ, Gamelli RL, Emanuele MA.

J Burn Care Res. 2008 May-Jun;29(3):531-40. doi: 10.1097/BCR.0b013e3181711273.

PMID:
18388566
42.

Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT).

Reaven PD, Emanuele N, Moritz T, Klein R, Davis M, Glander K, Duckworth W, Abraira C; Veterans Affairs Diabetes Trial.

Diabetes Care. 2008 May;31(5):952-7. doi: 10.2337/dc07-1926. Epub 2008 Mar 3.

PMID:
18316393
43.

Vitamin E prevents ethanol-induced inflammatory, hormonal, and cytotoxic changes in reproductive tissues.

Zhu Q, Emanuele MA, LaPaglia N, Kovacs EJ, Emanuele NV.

Endocrine. 2007 Aug;32(1):59-68. Epub 2007 Oct 16.

PMID:
17992603
44.

Effects of insulin on hepatic inflammation induced by ethanol and burn injury in a murine model of critical illness.

Emanuele MA, Emanuele NV, Gamelli RL, Kovacs EJ, LaPaglia N.

J Burn Care Res. 2007 May-Jun;28(3):490-9.

PMID:
17438481
45.

Visual vignette. Diagnosis: hypocalcemia due to primary hypoparathyroidism.

Sapountzi P, Emanuele NV, Loutrianakis E, Camacho PM.

Endocr Pract. 2006 Mar-Apr;12(2):233. No abstract available.

PMID:
16690474
46.
47.

Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial.

Emanuele N, Sacks J, Klein R, Reda D, Anderson R, Duckworth W, Abraira C; Veterans Affairs Diabetes Trial Group.

Diabetes Care. 2005 Aug;28(8):1954-8.

PMID:
16043738
48.

Health-related quality of life in the VA Feasibility Study on glycemic control and complications in type 2 diabetes mellitus.

Pitale S, Kernan-Schroeder D, Emanuele N, Sawin C, Sacks J, Abraira C; VACSDM Study Group.

J Diabetes Complications. 2005 Jul-Aug;19(4):207-11.

PMID:
15993354
49.

Ethanol-induced alterations in Rab proteins: possible implications for pituitary dysfunction.

Ren JC, Zhu Q, Lapaglia N, Emanuele NV, Emanuele MA.

Alcohol. 2005 Feb;35(2):103-12.

PMID:
15963423
50.

Exposure to ethanol induces oxidative damage in the pituitary gland.

Ren JC, Banan A, Keshavarzian A, Zhu Q, Lapaglia N, McNulty J, Emanuele NV, Emanuele MA.

Alcohol. 2005 Feb;35(2):91-101.

PMID:
15963422

Supplemental Content

Loading ...
Support Center